Pharma Co. Fights Rival's Blood Pressure Drug Patent
A pharmaceutical company has told a London court that a rival's treatment for high blood pressure infringes one of its patents, throwing a wrench in the rival's plans to keep selling...To view the full article, register now.
Already a subscriber? Click here to view full article